Search

Your search keyword '"Ahearn, T."' showing total 157 results

Search Constraints

Start Over You searched for: Author "Ahearn, T." Remove constraint Author: "Ahearn, T."
157 results on '"Ahearn, T."'

Search Results

1. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

2. Abnormal Temporal Difference Reward-Learning Signals in Major Depression

3. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

4. A Genome-Wide Gene-Based Gene-Environment Interaction Study of Breast Cancer in More than 90,000 Women

5. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

6. Rare germline copy number variants (CNVs) and breast cancer risk

7. CYP3A7*1C allele:linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

9. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

10. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

11. Breast cancer risk genes - Association analysis in more than 113,000 women.

12. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

13. Combined Associations of a Polygenic Risk Score and Classical Risk Factors with Breast Cancer Risk.

14. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

15. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk

16. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

17. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

18. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element

19. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

20. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

21. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

23. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

24. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

25. Two truncating variants in FANCC and breast cancer risk.

27. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

28. Two truncating variants in FANCC and breast cancer risk

29. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

30. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

33. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

34. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

35. Two truncating variants in FANCC and breast cancer risk

36. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

37. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes

40. P6203Intramyocellular lipid saturation as a new metabolic biomarker

41. Erratum: Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas

42. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas

43. PTU-181 Optimised response prediction in oesophagogastric adenocarcinomas (OGA) with combination of molecular biomarkers, serum cell death markers and FDG-PET

Catalog

Books, media, physical & digital resources